Search - tctmd.com

Displaying 901 - 920 of 1163

Sort: Relevancy | Date

Presentation TCT 2017

TRIGUARD Design Features and Clinical Findings From EU Clinical Trials

Presenter: Joachim Schofer

October 31, 2017

Presentation TCT 2017

A Propensity Score Analysis of Matched TAVR Patients With and Without Cerebral Protection

Presenter: Jochen Wöhrle

October 31, 2017

Presentation TCT 2017

SENTINEL Design Features and Findings From the Meta-Analysis of Three Randomized Clinical Trials

Presenter: Samir R. Kapadia

October 31, 2017

Presentation TCT 2017

TCT 52: Novel Preclinical Assessment of Transcatheter Mitral Valve Replacement by Micro-Computed Tomography: µCT Imaging-Guided Histopathological Evaluation

Presenter: Peter C. Block, Lars Sondergaard, Armando Tellez, MD

October 31, 2017

News Conference News TCT 2017

3-D Printing Opportunities Emerge for Cardiologists, Hospitals, and Device Companies Alike

Yael L. Maxwell

October 31, 2017

Presentation TCT 2017

How to Guide LAA Closure By ICE

Presenter: Rebecca T. Hahn, Fabian Nietlispach, Brij Maini

October 30, 2017

Presentation TCT 2017

Utility of CT Before LAA Closure and How to Image

Presenter: Rebecca T. Hahn, Fabian Nietlispach, Dee Dee Wang

October 30, 2017

Presentation TCT 2017

Amulet: Data Synthesis and Ongoing Trials

Presenter: William A. Gray, Vivek Y. Reddy, Fabian Nietlispach

October 30, 2017

Presentation TCT 2017

WATCHMAN: Data Synthesis and Ongoing Trials

Presenter: William A. Gray, Vivek Y. Reddy

October 30, 2017

Presentation TCT 2017

Do the PIONEER and RE-DUAL Results Alter LAA Closure Decisions?

Presenter: William A. Gray, Vivek Y. Reddy, C. Michael Gibson

October 30, 2017

Presentation TCT 2017

Should the Improved Results With NOACs Compared to Warfarin Change LAA Closure Decisions?

Presenter: William A. Gray, Vivek Y. Reddy, Kurt Huber

October 30, 2017

Presentation TCT 2017

Debate: LAA Closure Should Be Considered in Most Patients With Nonvalvular Atrial Fibrillation!

Presenter: Christopher B. Granger, Horst Sievert, Maurice Buchbinder

October 30, 2017

Presentation TCT 2017

Debate: LAA Closure Should Be Considered Only As a Last Resort Option!

Presenter: Christopher B. Granger, Horst Sievert, John M. Mandrola

October 30, 2017

Presentation TCT 2017

LAA Closure Plus ... TAVR, MitraClip, and More

Presenter: Christopher B. Granger, Horst Sievert, Samir R. Kapadia

October 30, 2017

Presentation TCT 2017

Catheter Ablation and/or LAA Closure for Atrial Fibrillation: Competitive or Complementary?

Presenter: Christopher B. Granger, Horst Sievert, Vivek Y. Reddy

October 30, 2017

Presentation TCT 2017

Use of Different Imaging Modalities to Conceptualize the 3-Dimensional Heart

Presenter: Paul A. Grayburn, Maurice E. Sarano, Nicolo Piazza

October 30, 2017

Presentation TCT 2017

Current Guidelines and Recommendations for LAA Closure in Nonvalvular Atrial Fibrillation

Presenter: Christopher B. Granger, Horst Sievert, Pascal Vranckx

October 30, 2017

Presentation TCT 2017

CT Imaging Essentials for Patient Selection of Mitraclip, Transcatheter Annuloplasty, and TMVR Procedures

Presenter: Paul A. Grayburn, Maurice E. Sarano, Jonathon A. Leipsic

October 30, 2017

Presentation TCT 2017

TEE Imaging Essentials for Patient Selection of Mitraclip, Transcatheter Annuloplasty, and TMVR Procedures

Presenter: Paul A. Grayburn, Maurice E. Sarano

October 30, 2017

Presentation TCT 2017

What Degree of MR Deserves Surgical or Transcatheter Intervention, and How Should It Be Assessed?

Presenter: Paul A. Grayburn, Maurice E. Sarano, Robert J. Siegel

October 30, 2017

Advertisement

TRIGUARD Design Features and Clinical Findings From EU Clinical Trials

A Propensity Score Analysis of Matched TAVR Patients With and Without Cerebral Protection

SENTINEL Design Features and Findings From the Meta-Analysis of Three Randomized Clinical Trials

TCT 52: Novel Preclinical Assessment of Transcatheter Mitral Valve Replacement by Micro-Computed Tomography: µCT Imaging-Guided Histopathological Evaluation

3-D Printing Opportunities Emerge for Cardiologists, Hospitals, and Device Companies Alike

How to Guide LAA Closure By ICE

Utility of CT Before LAA Closure and How to Image

Amulet: Data Synthesis and Ongoing Trials

WATCHMAN: Data Synthesis and Ongoing Trials

Do the PIONEER and RE-DUAL Results Alter LAA Closure Decisions?

Should the Improved Results With NOACs Compared to Warfarin Change LAA Closure Decisions?

Debate: LAA Closure Should Be Considered in Most Patients With Nonvalvular Atrial Fibrillation!

Debate: LAA Closure Should Be Considered Only As a Last Resort Option!

LAA Closure Plus ... TAVR, MitraClip, and More

Catheter Ablation and/or LAA Closure for Atrial Fibrillation: Competitive or Complementary?

Use of Different Imaging Modalities to Conceptualize the 3-Dimensional Heart

Current Guidelines and Recommendations for LAA Closure in Nonvalvular Atrial Fibrillation

CT Imaging Essentials for Patient Selection of Mitraclip, Transcatheter Annuloplasty, and TMVR Procedures

TEE Imaging Essentials for Patient Selection of Mitraclip, Transcatheter Annuloplasty, and TMVR Procedures

What Degree of MR Deserves Surgical or Transcatheter Intervention, and How Should It Be Assessed?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content